Industry Research Reports

Home > Reports > Medical Devices & Consumables > Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Devices & Consumables

Published Date: 2025-09-06

Pages: 78 Pages

Report ld: 5015384

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Congestive Heart Failure (CHF) Treatment Devices Market Size(US$)

CAGR 2025-2031

3.1%

Market Size,2031

USD 6,730

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 5,603 million

Market Forecast in 2031(Value)

US$ 6,730 million

CAGR

3.1%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Congestive Heart Failure (CHF) Treatment Devices market size was US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.

By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Congestive Heart Failure (CHF) Treatment Devices market competitiveness, regional economic performance, and supply chain configurations.

Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Congestive Heart Failure (CHF) Treatment Devices market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

By Company

Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)

Segment by Application

Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)

biaoTi Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Congestive Heart Failure (CHF) Treatment Devices market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Implantable Cardioverter Defibrillators (ICDs) in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Right Ventricular Assist Device (RVAD) in India).

Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

biaoTi Why This Report?

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

Table of Contents

1 Market Overview

1.1 Congestive Heart Failure (CHF) Treatment Devices Product Scope

1.2 Congestive Heart Failure (CHF) Treatment Devices by Type

1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2020 & 2024 & 2031)

1.2.2 Cardiac Resynchronization Therapy (CRT)

1.2.3 Implantable Cardioverter Defibrillators (ICDs)

1.3 Congestive Heart Failure (CHF) Treatment Devices by Application

1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Left Ventricular Assist Device (LVAD)

1.3.3 Right Ventricular Assist Device (RVAD)

1.3.4 Biventricular Assist Device (BIVAD)

1.4 Global Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts (2020-2031)

1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Congestive Heart Failure (CHF) Treatment Devices Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2020-2025)

2.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2020-2025)

2.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Size and Prospective (2020-2031)

2.4.2 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size and Prospective (2020-2031)

2.4.3 China Congestive Heart Failure (CHF) Treatment Devices Market Size and Prospective (2020-2031)

2.4.4 Japan Congestive Heart Failure (CHF) Treatment Devices Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Type (2020-2025)

3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2020-2025)

3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2020-2025)

3.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2020-2025)

3.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Type (2026-2031)

3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Type (2026-2031)

3.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Type (2026-2031)

3.3 Different Types Congestive Heart Failure (CHF) Treatment Devices Representative Players

4 Global Market Size by Application

4.1 Global Congestive Heart Failure (CHF) Treatment Devices Historic Market Review by Application (2020-2025)

4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2020-2025)

4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2020-2025)

4.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2020-2025)

4.2 Global Congestive Heart Failure (CHF) Treatment Devices Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Forecast by Application (2026-2031)

4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Forecast by Application (2026-2031)

4.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Congestive Heart Failure (CHF) Treatment Devices Application

5 Competition Landscape by Players

5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Players (2020-2025)

5.2 Global Top Congestive Heart Failure (CHF) Treatment Devices Players by Revenue (2020-2025)

5.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2024)

5.4 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Product Type & Application

5.7 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Company

6.1.1.1 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2020-2025)

6.1.1.2 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2020-2025)

6.1.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2020-2025)

6.1.3 North America Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2020-2025)

6.1.4 North America Congestive Heart Failure (CHF) Treatment Devices Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Company

6.2.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2020-2025)

6.2.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2020-2025)

6.2.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2020-2025)

6.2.3 Europe Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2020-2025)

6.2.4 Europe Congestive Heart Failure (CHF) Treatment Devices Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Congestive Heart Failure (CHF) Treatment Devices Sales by Company

6.3.1.1 China Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2020-2025)

6.3.1.2 China Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2020-2025)

6.3.2 China Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2020-2025)

6.3.3 China Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2020-2025)

6.3.4 China Congestive Heart Failure (CHF) Treatment Devices Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales by Company

6.4.1.1 Japan Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2020-2025)

6.4.1.2 Japan Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2020-2025)

6.4.2 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Type (2020-2025)

6.4.3 Japan Congestive Heart Failure (CHF) Treatment Devices Sales Breakdown by Application (2020-2025)

6.4.4 Japan Congestive Heart Failure (CHF) Treatment Devices Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 Abiomed

7.1.1 Abiomed Company Information

7.1.2 Abiomed Business Overview

7.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.1.5 Abiomed Recent Development

7.2 Berlin Heart GmbH

7.2.1 Berlin Heart GmbH Company Information

7.2.2 Berlin Heart GmbH Business Overview

7.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.2.5 Berlin Heart GmbH Recent Development

7.3 Biotronik SE & Co. KG

7.3.1 Biotronik SE & Co. KG Company Information

7.3.2 Biotronik SE & Co. KG Business Overview

7.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.3.5 Biotronik SE & Co. KG Recent Development

7.4 Boston Scientific Corporation

7.4.1 Boston Scientific Corporation Company Information

7.4.2 Boston Scientific Corporation Business Overview

7.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.4.5 Boston Scientific Corporation Recent Development

7.5 HeartWare International

7.5.1 HeartWare International Company Information

7.5.2 HeartWare International Business Overview

7.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.5.5 HeartWare International Recent Development

7.6 Jarvik Heart

7.6.1 Jarvik Heart Company Information

7.6.2 Jarvik Heart Business Overview

7.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.6.5 Jarvik Heart Recent Development

7.7 LivaNova PLC

7.7.1 LivaNova PLC Company Information

7.7.2 LivaNova PLC Business Overview

7.7.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.7.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.7.5 LivaNova PLC Recent Development

7.8 Medtronic

7.8.1 Medtronic Company Information

7.8.2 Medtronic Business Overview

7.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.8.5 Medtronic Recent Development

7.9 ReliantHeart

7.9.1 ReliantHeart Company Information

7.9.2 ReliantHeart Business Overview

7.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.9.5 ReliantHeart Recent Development

7.10 Abbott

7.10.1 Abbott Company Information

7.10.2 Abbott Business Overview

7.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Products Offered

7.10.5 Abbott Recent Development

8 Congestive Heart Failure (CHF) Treatment Devices Manufacturing Cost Analysis

8.1 Congestive Heart Failure (CHF) Treatment Devices Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices

8.4 Congestive Heart Failure (CHF) Treatment Devices Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Congestive Heart Failure (CHF) Treatment Devices Distributors List

9.3 Congestive Heart Failure (CHF) Treatment Devices Customers

10 Congestive Heart Failure (CHF) Treatment Devices Market Dynamics

10.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends

10.2 Congestive Heart Failure (CHF) Treatment Devices Market Drivers

10.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges

10.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

Table of Figures

List of Tables

Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Congestive Heart Failure (CHF) Treatment Devices Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Region (2020-2025)

Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2020-2025)

Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Region (2020-2025)

Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Forecast by Region (2026-2031)

Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share Forecast by Region (2026-2031)

Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (K Units) & (2020-2025)

Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2020-2025)

Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (USD/Unit) & (2020-2025)

Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (K Units) & (2026-2031)

Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (USD/Unit) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (K Units) & (2020-2025)

Table 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2020-2025)

Table 22. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (USD/Unit) & (2020-2025)

Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (K Units) & (2026-2031)

Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (USD/Unit) & (2026-2031)

Table 27. New Sources of Growth in Congestive Heart Failure (CHF) Treatment Devices Application

Table 28. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Company (K Units) & (2020-2025)

Table 29. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Company (2020-2025)

Table 30. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Company (2020-2025)

Table 32. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2024)

Table 33. Global Market Congestive Heart Failure (CHF) Treatment Devices Average Price by Company (USD/Unit) & (2020-2025)

Table 34. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Product Type & Application

Table 36. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2020-2025) & (K Units)

Table 39. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2020-2025)

Table 40. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2020-2025)

Table 42. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2020-2025) & (K Units)

Table 43. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2020-2025)

Table 44. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2020-2025) & (K Units)

Table 45. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2020-2025)

Table 46. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2020-2025) & (K Units)

Table 47. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2020-2025)

Table 48. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2020-2025)

Table 50. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2020-2025) & (K Units)

Table 51. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2020-2025)

Table 52. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2020-2025) & (K Units)

Table 53. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2020-2025)

Table 54. China Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2020-2025) & (K Units)

Table 55. China Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2020-2025)

Table 56. China Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2020-2025)

Table 58. China Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2020-2025) & (K Units)

Table 59. China Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2020-2025)

Table 60. China Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2020-2025) & (K Units)

Table 61. China Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2020-2025)

Table 62. Japan Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2020-2025) & (K Units)

Table 63. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2020-2025)

Table 64. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2020-2025)

Table 66. Japan Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2020-2025) & (K Units)

Table 67. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2020-2025)

Table 68. Japan Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2020-2025) & (K Units)

Table 69. Japan Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2020-2025)

Table 70. Abiomed Company Information

Table 71. Abiomed Description and Business Overview

Table 72. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product

Table 74. Abiomed Recent Development

Table 75. Berlin Heart GmbH Company Information

Table 76. Berlin Heart GmbH Description and Business Overview

Table 77. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product

Table 79. Berlin Heart GmbH Recent Development

Table 80. Biotronik SE & Co. KG Company Information

Table 81. Biotronik SE & Co. KG Description and Business Overview

Table 82. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product

Table 84. Biotronik SE & Co. KG Recent Development

Table 85. Boston Scientific Corporation Company Information

Table 86. Boston Scientific Corporation Description and Business Overview

Table 87. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product

Table 89. Boston Scientific Corporation Recent Development

Table 90. HeartWare International Company Information

Table 91. HeartWare International Description and Business Overview

Table 92. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product

Table 94. HeartWare International Recent Development

Table 95. Jarvik Heart Company Information

Table 96. Jarvik Heart Description and Business Overview

Table 97. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product

Table 99. Jarvik Heart Recent Development

Table 100. LivaNova PLC Company Information

Table 101. LivaNova PLC Description and Business Overview

Table 102. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product

Table 104. LivaNova PLC Recent Development

Table 105. Medtronic Company Information

Table 106. Medtronic Description and Business Overview

Table 107. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product

Table 109. Medtronic Recent Development

Table 110. ReliantHeart Company Information

Table 111. ReliantHeart Description and Business Overview

Table 112. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product

Table 114. ReliantHeart Recent Development

Table 115. Abbott Company Information

Table 116. Abbott Description and Business Overview

Table 117. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Abbott Congestive Heart Failure (CHF) Treatment Devices Product

Table 119. Abbott Recent Development

Table 120. Production Base and Market Concentration Rate of Raw Material

Table 121. Key Suppliers of Raw Materials

Table 122. Congestive Heart Failure (CHF) Treatment Devices Distributors List

Table 123. Congestive Heart Failure (CHF) Treatment Devices Customers List

Table 124. Congestive Heart Failure (CHF) Treatment Devices Market Trends

Table 125. Congestive Heart Failure (CHF) Treatment Devices Market Drivers

Table 126. Congestive Heart Failure (CHF) Treatment Devices Market Challenges

Table 127. Congestive Heart Failure (CHF) Treatment Devices Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Congestive Heart Failure (CHF) Treatment Devices Product Picture

Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type in 2024 & 2031

Figure 4. Cardiac Resynchronization Therapy (CRT) Product Picture

Figure 5. Implantable Cardioverter Defibrillators (ICDs) Product Picture

Figure 6. Global Congestive Heart Failure (CHF) Treatment Devices Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 7. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application in 2024 & 2031

Figure 8. Left Ventricular Assist Device (LVAD) Examples

Figure 9. Right Ventricular Assist Device (RVAD) Examples

Figure 10. Biventricular Assist Device (BIVAD) Examples

Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Sales Growth Rate (2020-2031) & (US$ Million)

Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Growth Rate (2020-2031)

Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Price Trends Growth Rate (2020-2031) & (USD/Unit)

Figure 15. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered

Figure 16. Global Market Congestive Heart Failure (CHF) Treatment Devices Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region: 2020 VS 2024

Figure 18. North America Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. North America Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Growth Rate (2020-2031)

Figure 20. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. Europe Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Growth Rate (2020-2031)

Figure 22. China Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. China Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Growth Rate (2020-2031)

Figure 24. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) Growth Rate (2020-2031)

Figure 25. Japan Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) Growth Rate (2020-2031)

Figure 26. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2020-2025)

Figure 27. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Type (2026-2031)

Figure 28. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Type (2026-2031)

Figure 29. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2020-2025)

Figure 30. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate by Application in 2020 & 2024

Figure 31. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Application (2026-2031)

Figure 32. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Application (2026-2031)

Figure 33. Global Congestive Heart Failure (CHF) Treatment Devices Sales Share by Company (2024)

Figure 34. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Company (2024)

Figure 35. Global 5 Largest Congestive Heart Failure (CHF) Treatment Devices Players Market Share by Revenue in Congestive Heart Failure (CHF) Treatment Devices: 2020 & 2024

Figure 36. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 37. Manufacturing Cost Structure of Congestive Heart Failure (CHF) Treatment Devices

Figure 38. Manufacturing Process Analysis of Congestive Heart Failure (CHF) Treatment Devices

Figure 39. Congestive Heart Failure (CHF) Treatment Devices Industrial Chain

Figure 40. Channels of Distribution (Direct Vs Distribution)

Figure 41. Distributors Profiles

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

Related Reports

Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2024
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-01-16
Pages: 94
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-01-24
Pages: 123
USD 3950.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published Date: 2024-04-12
Pages: 107
USD 4900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
The global market for Congestive Heart Failure (CHF) Treatment Devices was valued at US$ 5451 million in the year 2024 and is projected to reach a revised size of US$ 6730 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published Date: 2025-02-25
Pages: 86
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published Date: 2025-02-25
Pages: 110
USD 3950.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5451 million in 2024 to US$ 6730 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-30
Pages: 132
USD 4900.00
(Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2026
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 5603 million in 2025 and is anticipated to reach US$ 6918 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-04-27
Pages: 115
USD 2900.00
(Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5603 million in 2025 and is projected to reach US$ 6918 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 135
USD 3950.00
(Single User License)

Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2024
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-01-16
Pages: 94
USD 2900.00 (Single User License)
Congestive Heart Failure (CHF) Treatment Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-01-24
Pages: 123
USD 3950.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Insights, Forecast to 2030
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
Published: 2024-04-12
Pages: 107
USD 4900.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
The global market for Congestive Heart Failure (CHF) Treatment Devices was valued at US$ 5451 million in the year 2024 and is projected to reach a revised size of US$ 6730 million by 2031, growing at a CAGR of 3.1% during the forecast period.
Published: 2025-02-25
Pages: 86
USD 2900.00 (Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5451 million in 2024 and is forecast to a readjusted size of US$ 6730 million by 2031 with a CAGR of 3.1% during the forecast period 2025-2031.
Published: 2025-02-25
Pages: 110
USD 3950.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Congestive Heart Failure (CHF) Treatment Devices market is projected to grow from US$ 5451 million in 2024 to US$ 6730 million by 2031, at a CAGR of 3.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-30
Pages: 132
USD 4900.00 (Single User License)
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2026
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 5603 million in 2025 and is anticipated to reach US$ 6918 million by 2032, at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-04-27
Pages: 115
USD 2900.00 (Single User License)
Congestive Heart Failure (CHF) Treatment Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Congestive Heart Failure (CHF) Treatment Devices was estimated to be worth US$ 5603 million in 2025 and is projected to reach US$ 6918 million, growing at a CAGR of 3.1% from 2026 to 2032.
Published: 2026-07-14
Pages: 135
USD 3950.00 (Single User License)